B3 Vertaisarvioimaton artikkeli konferenssijulkaisussa

Exploring optoretinographic responses of photoreceptor function in disease-affected retinas




TekijätMaddipatla Reddikumar, Langlo Christopher S., Vienola Kari V., Bartuzel Maciej M., Pijewska Ewelina, Zawadzki Robert J., Jonnal Ravi S.

ToimittajaDaniel X. Hammer, Kostadinka Bizheva, Georg Schuele

Konferenssin vakiintunut nimiSPIE BiOS

Julkaisuvuosi2024

JournalProgress in Biomedical Optics and Imaging

Kokoomateoksen nimiOphthalmic Technologies XXXIV

Artikkelin numero1282406

Sarjan nimiOphthalmic Technologies

Numero sarjassa34

Vuosikerta12824

Aloitussivu1

Lopetussivu10

ISBN978-1-5106-6907-9

eISBN978-1-5106-6908-6

DOIhttps://doi.org/10.1117/12.3003007

Verkko-osoitehttps://www.spiedigitallibrary.org/conference-proceedings-of-spie/12824/1282406/Exploring-optoretinographic-responses-of-photoreceptor-function-in-disease-affected-retinas/10.1117/12.3003007.short

Rinnakkaistallenteen osoitehttps://research.utu.fi/converis/portal/detail/Publication/387370277


Tiivistelmä

Assessment of the functional response of photoreceptors plays an important role in assessing and treating vision loss. Optoretinography (ORG) is an emerging non-invasive technique that measures the photoreceptors’ functional response to external light stimuli using optical coherence tomography (OCT) or other phase-sensitive imaging modalities. Recently a novel velocity-based ORG method was demonstrated, illustrating the feasibility of measuring photoreceptor function with clinical-grade OCT systems. Here we test this technique on diseaseaffected retinae of human subjects. The disease-affected retinae exhibited altered responses when compared to a healthy volunteer. The findings indicate promise for this novel tool to find applications in the clinic and clinical research.


Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2025-28-02 at 14:53